GUMM - Eliminate the Common Cold Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: out_of_the_loop who wrote (1860)	12/8/1999 2:28:00 PM
From: DanZ	Read Replies (1) of 5582

Wednesday December 8, 2:00 pm Eastern Time Former FTC Associate Director Says FTC Leaves COLD-EEZE(R) Core Claim Untouched DOYLESTOWN, Pa., Dec. 8 /PRNewswire/ -- A former associate director of the Federal Trade Commission said that a recent FTC review of advertising claims for COLD-EEZE© lozenges left untouched its core claim that the product reduces the duration and severity of common cold symptoms. <more> biz.yahoo.com This caused quite a pop in QGLY's stock. It might have a spillover effect on GUMM once it gets out. This reafirms what many of us already believe: that zinc reduces the duration and severity of the common cold. Zicam just does it better than Cold Eeze, and that's one reason that Quigley's sales are falling while Gum Tech's are soaring. Dan

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next